Dr. Aaron Miller: "Biogen MS Drug Results Are 'Mildly Encouraging' In Eye Disease Test"
Results from using Biogen's experimental nerve repair drug in a disease of the eye were "mildly encouraging," experts say, keeping alive the hope that the medicine might work in multiple sclerosis. The drug, known as Anti-LINGO-1, is promising because it is the first medicine to try to repair damaged nerves in diseases like MS. "This is the first time that there is anything that has really shown a result where there is repair of an existing nerve," says Aaron Miller, MD, an MS expert at the Icahn School of Medicine at Mount Sinai. This is evidence of such repair, although Miller notes that it is "relatively soft." Learn more
Scientists Develop Novel Approach to Enhance Drug Delivery for Brain Tumors in Children
Mar 02, 2023 View All Press Releases
Researchers Identify the Role of an Alzheimer’s Disease Risk Gene in the Brain
Nov 30, 2022 View All Press Releases
